BRIEF published on 12/17/2025 at 19:35, 2 months 29 days ago Leadership Change at Accor's Board Board Of Directors Accor Leadership Change Hospitality Industry Nicolas Sarkozy
REGULATED PRESS RELEASE published on 12/17/2025 at 19:30, 2 months 29 days ago Change in the composition of the Board Accor's Board of Directors acknowledges the resignation of Mr. Nicolas Sarkozy as Director. The Board expresses gratitude for his contributions and strategic vision Board Of Directors Accor Resignation Strategic Vision Nicolas Sarkozy
BRIEF published on 12/17/2025 at 17:50, 2 months 29 days ago Accor Adjusts Timing of Share Buyback Program Launch Accor Regulatory Compliance Share Buyback Essendi Insider Information
REGULATED PRESS RELEASE published on 12/17/2025 at 17:45, 2 months 29 days ago Adjustment in the timing of the launch of a new share buyback program Accor postpones €100 million share buyback program launch from Q4 2025 to Q1 2026 due to insider information on Essendi stake disposal progress Accor Share Buyback Postpone Essendi Insider Information
BRIEF published on 12/03/2025 at 10:44, 3 months 12 days ago Accor's Updated Share Capital and Voting Rights Share Capital Voting Rights French Commercial Code Accor December 2025
REGULATED PRESS RELEASE published on 12/03/2025 at 10:39, 3 months 12 days ago Disclosure of shares outstanding and voting rights - 03.12.2025 Accor discloses share capital & voting rights as of November 30, 2025 as per French Commercial Code. For more info, visit https://group.accor.com/en Share Capital Voting Rights French Commercial Code Accor Disclosure
BRIEF published on 11/04/2025 at 16:05, 4 months 11 days ago Accor's Share Capital and Voting Rights Update Share Capital Voting Rights Accor Disclosure November 2025
REGULATED PRESS RELEASE published on 11/04/2025 at 16:00, 4 months 11 days ago Disclosure of shares outstanding and voting rights - 04.11.2025 Accor discloses share capital and voting rights for October 31, 2025, in accordance with French Commercial Code. Total potential and exercisable voting rights provided Share Capital Voting Rights French Commercial Code Accor Disclosure
BRIEF published on 10/03/2025 at 09:05, 5 months 12 days ago Accor's September 2025 Share Capital and Voting Rights Information Share Capital Voting Rights French Commercial Code Accor September 2025
REGULATED PRESS RELEASE published on 10/03/2025 at 09:00, 5 months 12 days ago Disclosure of shares outstanding and voting rights - 03.10.2025 Accor discloses Share Capital and Voting Rights as of September 30, 2025, in accordance with French Commercial Code. Total potential voting rights: 285,067,005 Exercisable voting rights: 274,182,613 Share Capital Voting Rights French Commercial Code Accor Disclosure
Published on 03/15/2026 at 23:25, 8 hours 27 minutes ago Tunkillia 'Phase 2' Resource Upgrade Drilling Begins
Published on 03/15/2026 at 18:00, 13 hours 52 minutes ago SEG Announced 2025 Annual Results Initiating First Special Dividend Distribution Payout Ratio Reached 88% Newly Signed Orders Exceeded RMB100-Billion Mark for the Second Consecutive Year
Published on 03/13/2026 at 23:00, 2 days 8 hours ago CORRECTION FROM SOURCE: EV Nickel Announces Maiden Mineral Resource Estimate for Gemini North Nickel Zone
Published on 03/13/2026 at 23:00, 2 days 8 hours ago Redwood AI Announces Platform Name Change and Appointment of Dr. Mark Dybul as Public Safety & Defense Advisor
Published on 03/13/2026 at 21:30, 2 days 10 hours ago Alset AI Announces Closing of Shares for Debt Transaction
Published on 03/16/2026 at 07:30, 22 minutes ago Mutares posts another record year: According to preliminary, unaudited figures, Mutares increases Group revenues and Holding’s net income in the fiscal year 2025 – medium-term targets raised to 25%...
Published on 03/16/2026 at 07:24, 27 minutes ago EQS-Adhoc: UBS AG: UBS publishes agenda for its Annual General Meeting on 15 April 2026
Published on 03/16/2026 at 07:05, 47 minutes ago Hypoport delivers solid gross margin growth and disproportionate EBIT increase in 2025
Published on 03/16/2026 at 07:02, 49 minutes ago Changes to the Board of Directors of Julius Baer Group
Published on 03/16/2026 at 07:00, 52 minutes ago BioVersys Receives Green Light from US FDA for BV100 HABP/VABP Phase 3 Pivotal Trial Start
Published on 03/13/2026 at 19:50, 2 days 12 hours ago Availability of ENGIE’S 2025 Universal Registration Document
Published on 03/13/2026 at 18:05, 2 days 13 hours ago Availability of the 2025 Universal Registration Document of OPmobility SE
Published on 03/13/2026 at 07:30, 3 days ago BIOPHYTIS PRESENTS ITS DEVELOPMENT PROGRAMS IN OBESITY AND SARCOPENIA AT THE ICFSR CONFERENCE
Published on 03/12/2026 at 18:00, 3 days 13 hours ago NEW OR RENEWED AGREEMENTS BETWEEN EURAZEO AND CERTAIN FAMILY SHAREHOLDERS
Published on 03/12/2026 at 15:06, 3 days 16 hours ago FIERA MILANO: THE BOARD OF DIRECTORS APPROVES THE CONSOLIDATED RESULTS AS OF 31 DECEMBER 2025
